In LIHC, CD161 was mainly expressed in various cell types, including T cells, Thymic Epithelial Cell (TEC), B cells, Tumor-Associated Macrophage (TAM), fibroblasts, hematopoietic progenitor cell (HPC-like) and cancer cells (Figure S5A). Here, KLRB1 is linked to cancer.